BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Treatment
64 results:

  • 1. Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma cell Line SK-N-BE(2) Independent of Itraconazole.
    Liu X; Wang Z; Xiong X; Li C; Wu Y; Su M; Yang S; Zeng M; Weng W; Huang K; Zhou D; Fang J; Xu L; Li P; Zhu Y; Qiu K; Ma Y; Lei J; Li Y
    Anticancer Agents Med Chem; 2023; 23(20):2217-2224. PubMed ID: 37888819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
    Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
    Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. smo-CRISPR-mediated apoptosis in CD133-targeted cancer stem cells and tumor growth inhibition.
    Pandey S; Lee M; Lim J; Park S; Choung YH; Kim JE; Garg P; Chung JH
    J Control Release; 2023 May; 357():94-108. PubMed ID: 36931470
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. circRNA-smo upregulates CEP85 to promote proliferation and migration of glioblastoma via sponging miR-326.
    Wu B; Xia L; Zhang S; Jin K; Li L; Sun C; Xia T; Chen G
    Histol Histopathol; 2023 Nov; 38(11):1307-1319. PubMed ID: 36718820
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
    Sloan AE; Nock CJ; Ye X; Buerki R; Chang S; Lesser G; Norden A; Cloughesy T; Olson J; Kerstetter-Fogle A; Rich J; Fisher J; Desideri S; Takebe N; Timmer W; Grossman S; Prados M
    J Neurooncol; 2023 Jan; 161(1):33-43. PubMed ID: 36581779
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Noncanonical activation of GLI signaling in SOX2
    Swiderska-Syn M; Mir-Pedrol J; Oles A; Schleuger O; Salvador AD; Greiner SM; Seward C; Yang F; Babcock BR; Shen C; Wynn DT; Sanchez-Mejias A; Gershon TR; Martin V; McCrea HJ; Lindsey KG; Krieg C; Rodriguez-Blanco J
    Sci Adv; 2022 Jul; 8(29):eabj9138. PubMed ID: 35857834
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway.
    Gong W; Zhao W; Liu G; Shi L; Zhao X
    Aging (Albany NY); 2022 Jul; 14(13):5464-5477. PubMed ID: 35802536
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.
    de Almeida Magalhães T; Alencastro Veiga Cruzeiro G; Ribeiro de Sousa G; Englinger B; Fernando Peinado Nagano L; Ancliffe M; Rodrigues da Silva K; Jiang L; Gojo J; Cherry Liu Y; Carline B; Kuchibhotla M; Pinto Saggioro F; Kazue Nagahashi Marie S; Mieko Oba-Shinjo S; Andres Yunes J; Gomes de Paula Queiroz R; Alberto Scrideli C; Endersby R; Filbin MG; Silva Borges K; Salic A; Gonzaga Tone L; Valera ET
    Neuro Oncol; 2023 Jan; 25(1):185-198. PubMed ID: 35640920
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting AKT and CK2 represents a novel therapeutic strategy for smo constitutive activation-driven medulloblastoma.
    Yao YL; Wang YX; Yang FC; Wang C; Mao M; Gai QJ; He J; Qin Y; Yao XX; Lan X; Zhu J; Lu HM; Zeng H; Yao XH; Bian XW; Wang Y
    CNS Neurosci Ther; 2022 Jul; 28(7):1033-1044. PubMed ID: 35419951
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Medulloblastoma].
    Kanemura Y
    No Shinkei Geka; 2022 Jan; 50(1):73-90. PubMed ID: 35169088
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients.
    Dunjic M; Lukic N; Djordjevic B; Uzelac B; Ostojic N; Supic G
    Melanoma Res; 2022 Feb; 32(1):11-17. PubMed ID: 34939981
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. STAT3 is required for smo-dependent signaling and mediates smo-targeted treatment resistance and tumorigenesis in Shh medulloblastoma.
    Yuan L; Zhang H; Liu J; Malhotra A; Dey A; Yu B; Jella KK; McSwain LF; Schniederjan MJ; MacDonald TJ
    Mol Oncol; 2022 Feb; 16(4):1009-1025. PubMed ID: 34482626
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. G-protein-coupled receptors as therapeutic targets for glioblastoma.
    Byrne KF; Pal A; Curtin JF; Stephens JC; Kinsella GK
    Drug Discov Today; 2021 Dec; 26(12):2858-2870. PubMed ID: 34271165
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.
    Saddozai UAK; Wang F; Akbar MU; Zhang L; An Y; Zhu W; Xie L; Li Y; Ji X; Guo X
    Front Endocrinol (Lausanne); 2021; 12():605797. PubMed ID: 34234737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma.
    Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ
    Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
    Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
    Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Steroidal alkaloids isolated from Veratrum grandiflorum Loes. as novel smoothened inhibitors with anti-proliferation effects on DAOY medulloblastoma cells.
    Gao LJ; Zhang MZ; Li XY; Huang WK; Xu SF; Ye YP
    Bioorg Med Chem; 2021 Jun; 39():116166. PubMed ID: 33910157
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator.
    Korshunov A; Okonechnikov K; Stichel D; Ryzhova M; Schrimpf D; Sahm F; Sievers P; Absalyamova O; Zheludkova O; Golanov A; Jones DTW; Pfister SM; von Deimling A; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1576-1585. PubMed ID: 33589929
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel protein encoded by circular smo RNA is essential for Hedgehog signaling activation and glioblastoma tumorigenicity.
    Wu X; Xiao S; Zhang M; Yang L; Zhong J; Li B; Li F; Xia X; Li X; Zhou H; Liu D; Huang N; Yang X; Xiao F; Zhang N
    Genome Biol; 2021 Jan; 22(1):33. PubMed ID: 33446260
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical and mutational profiles of adult medulloblastoma groups.
    Wong GC; Li KK; Wang WW; Liu AP; Huang QJ; Chan AK; Poon MF; Chung NY; Wong QH; Chen H; Chan DTM; Liu XZ; Mao Y; Zhang ZY; Shi ZF; Ng HK
    Acta Neuropathol Commun; 2020 Nov; 8(1):191. PubMed ID: 33172502
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.